Connection

Marshall Chew to Costs and Cost Analysis

Back to Details
This is a "connection" page, showing publications Marshall Chew has written about Costs and Cost Analysis.
Marshall Chew
Connection Strength
0.044
Costs and Cost Analysis
  1. A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment. Hosp Pediatr. 2021 01; 11(1):88-93.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.